8/31
12:42 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
Medium
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
8/31
12:42 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
Medium
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
8/30
12:16 pm
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Medium
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
8/30
11:56 am
artv
Rating for ARTV
Low
Report
Rating for ARTV
8/30
11:56 am
artv
Rating for ARTV
Low
Report
Rating for ARTV
8/13
09:35 am
artv
Rating for ARTV
Low
Report
Rating for ARTV
8/13
09:35 am
artv
Rating for ARTV
Low
Report
Rating for ARTV
8/13
08:43 am
artv
Rating for ARTV
Low
Report
Rating for ARTV
8/13
08:43 am
artv
Rating for ARTV
Low
Report
Rating for ARTV
8/13
07:54 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $23.00 price target on the stock.
Low
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $23.00 price target on the stock.
8/13
07:54 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $23.00 price target on the stock.
Low
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $23.00 price target on the stock.
8/13
07:54 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Wedbush. They set an "outperform" rating and a $18.00 price target on the stock.
Low
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Wedbush. They set an "outperform" rating and a $18.00 price target on the stock.
8/13
07:54 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Wedbush. They set an "outperform" rating and a $18.00 price target on the stock.
Low
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Wedbush. They set an "outperform" rating and a $18.00 price target on the stock.
8/13
07:24 am
artv
Rating for ARTV
Low
Report
Rating for ARTV
8/13
06:39 am
artv
Rating for ARTV
Low
Report
Rating for ARTV
8/13
06:39 am
artv
Rating for ARTV
Low
Report
Rating for ARTV
8/13
06:38 am
artv
Artiva Biotherapeutics initiated with bullish view at Wedbush
Low
Report
Artiva Biotherapeutics initiated with bullish view at Wedbush
8/13
06:38 am
artv
Artiva Biotherapeutics initiated with bullish view at Wedbush
Low
Report
Artiva Biotherapeutics initiated with bullish view at Wedbush
8/13
06:38 am
artv
Artiva Biotherapeutics initiated with bullish view at Wedbush
Low
Report
Artiva Biotherapeutics initiated with bullish view at Wedbush
8/13
06:38 am
artv
Artiva Biotherapeutics initiated with bullish view at Wedbush
Low
Report
Artiva Biotherapeutics initiated with bullish view at Wedbush
8/13
06:15 am
artv
Artiva Biotherapeutics initiated with bullish view at Cantor Fitzgerald
Low
Report
Artiva Biotherapeutics initiated with bullish view at Cantor Fitzgerald